- Location
adverse events
"-
Australian Government Make New Policy Related to The Medical
Feb 15, 2015Australian Prime Minister Tony Abbott began waging a war against red tape, even launching a website dedicated to the notion. The deregulation of the country’s medical device and pharmaceutical industries has been included in that ...
Tags: Medical Device, Medicine
-
FDA's First Weight-Loss Device TP for Obese Adults to Dieting and Having Bariatric Surgery
Jan 19, 2015The EnterMedics Maestro Rechargeable System weight loss treatment device is effective although scientists are unclear why. The FDA has approved the first weight-loss device since 2007, giving obese adults an alternative to dieting and ...
-
Puritan Bennett 980 Ventilator Has Been Recalled for Potential Software Issues
Nov 10, 2014Covidien described its new Puritan Bennett 980 ventilator as “simple, safe, and smart” when it won regulatory approval in the U.S. and Europe in early 2014. But half a year later, it is now the subject of a Class I-level recall ...
-
Recent Disappointing Results for Ventricular Assist Device Companies
Nov 10, 2014Recent disappointing results for ventricular assist device companies are raising questions over adoption of the technology—which is meant to assist patients’ weakened hearts with pumping blood. HeartMate II, as shown on ...
-
Mozambique May Produce 110,000 Tons of Cotton in The Current Marketing Year 2013-14
Mar 24, 2014Mozambique, a country in southeastern Africa, is likely to produce 110,000 tons of cotton in the current marketing year 2013-14, daily newspaper Noticias reported. Cotton production in Mozambique grew from 41,000 tons in 2009-10 ...
Tags: Mozambique, Cotton, cash crop
-
An Apple a Day Really Does Keep The Doctor Away, Research Shows
Feb 27, 2014February 17, 2014 Sophie Langley An apple a day really does keep the doctor away, research shows Prescribing an apple a day to all adults aged 50 and over would prevent or delay around 8,500 vascular deaths such as heart attacks and ...
Tags: an Apple
-
Elderly Kidney Cancer Patients Benefit From Sunitinib Therapy
Feb 27, 2014By Sara Freeman, medwireNews Reporter Elderly kidney cancer patients benefit from sunitinib therapy just as much as their younger counterparts, a retrospective analysis of six clinical trials shows. Median progression-free survival ...
Tags: PFS, mRCC, Advanced Age, IFN
-
Patients with Advanced Renal Cell Carcinoma Are on and off Treatment
Feb 27, 2014By Sara Freeman, medwireNews Reporter mewireNews: Shortening the time that patients with advanced renal cell carcinoma are on and off treatment with sunitinib improves the drug’s overall tolerability without affecting its efficacy, ...
Tags: ORR, Tolerability, PFS, Sunitinib
-
Advanced Breast Cancer Has Identified Individuals with a Good Chance
Feb 25, 2014The first large-scale study testing all the DNA—the entire genome—of tumour cells from more than 400 women with advanced breast cancer has identified individuals with a good chance of benefiting from specific treatments already ...
Tags: CGH, SAFIR01, DNA, Gustave Roussy
-
Children and Adolescents with Peanut Allergies Could Benefit From Treatment with OIT
Feb 25, 2014Children and adolescents with peanut allergies could benefit from treatment with oral immunotherapy (OIT), in which peanut protein is consumed in increasingly larger amounts on a regular basis to build up tolerance, according to a phase 2 ...
Tags: Peanut Allergies, peanut protein, mild with oral itching
-
Valproic Acid Is One of The Most Widely Prescribed Drugs for The Treatment of Epilepsy
Feb 18, 2014Valproic acid is one of the most widely prescribed drugs for the treatment of epilepsy. It has also been shown to be effective for the treatment of mood disorders and migraine headaches. What prompted your research into valproic acid ...
Tags: Valproic Acid, Health, Medicine
-
Palbociclib Received Breakthrough Therapy Designation by The United States Food
Feb 14, 2014Pfizer Inc. (NYSE:PFE) today announced that the randomized Phase 2 trial [PALOMA-1] of palbociclib achieved its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival ...
Tags: Health&Medicine
-
CHMP Has Issued a Positive Opinion for The Use of Novartis' Xolair as an Add-on Therapy
Feb 10, 2014The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Novartis’ Xolair (omalizumab) as an add-on therapy for the treatment of chronic spontaneous ...
-
Omeros Corporation Announced Positive Results From a Phase 2A Clinical Trial of OMS824
Feb 7, 2014Omeros Corporation (NASDAQ: OMER) today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic ...